These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6105889)

  • 21. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.
    Craven PA; DeRubertis FR
    J Biol Chem; 1978 Dec; 253(23):8433-43. PubMed ID: 30778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
    Isono T; Sato N; Yamamoto T; Sawada T; Yamazaki S; Miura S; Furuichi A; Ozaki R; Koibuchi Y; Ohtsuka M
    Eur J Pharmacol; 1994 Aug; 260(2-3):163-8. PubMed ID: 7988640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nitric oxide donors on Ca2+-dependent [14C]GABA release from brain synaptosomes: the role of SH-groups.
    Nedvetsky PI; Konev SV; Rakovich AA; Petrenko SV; Mongin AA
    Biochemistry (Mosc); 2000 Sep; 65(9):1027-35. PubMed ID: 11042494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts.
    Schröder H; Leitman DC; Bennett BM; Waldman SA; Murad F
    J Pharmacol Exp Ther; 1988 May; 245(2):413-8. PubMed ID: 2452870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside.
    Kamisaki Y; Waldman SA; Murad F
    Arch Biochem Biophys; 1986 Dec; 251(2):709-14. PubMed ID: 2879512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of sulfhydryl groups in the oxidative modulation of particulate lung guanylate cyclase by nitric oxide and N-methyl-N'nitro-N-nitrosoguanidine.
    Braughler JM
    Biochem Pharmacol; 1982 Apr; 31(7):1239-44. PubMed ID: 6124254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of nitrovasodilator bioactivation.
    Noack E; Feelisch M
    Basic Res Cardiol; 1991; 86 Suppl 2():37-50. PubMed ID: 1683227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.
    Feelisch M; Schönafinger K; Noack E
    Biochem Pharmacol; 1992 Sep; 44(6):1149-57. PubMed ID: 1358072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of SH-groups in guanidine thiols--new substrates for NO-synthase--in stimulating the activity of guanylate cyclase].
    Busygina OG; Grigor'ev NB; Severina IS
    Biokhimiia; 1996 Jan; 61(1):119-25. PubMed ID: 8679771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.
    Craven PA; DeRubertis FR
    Biochim Biophys Acta; 1983 Jun; 745(3):310-21. PubMed ID: 6134553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
    Ignarro LJ; Lippton H; Edwards JC; Baricos WH; Hyman AL; Kadowitz PJ; Gruetter CA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):739-49. PubMed ID: 6115052
    [No Abstract]   [Full Text] [Related]  

  • 33. Under anaerobic conditions, soluble guanylate cyclase is specifically stimulated by glutathione.
    Niroomand F; Rössle R; Mülsch A; Böhme E
    Biochem Biophys Res Commun; 1989 May; 161(1):75-80. PubMed ID: 2567167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasodilator actions of several N-nitroso compounds.
    Lippton HL; Gruetter CA; Ignarro LJ; Meyer RL; Kadowitz PJ
    Can J Physiol Pharmacol; 1982 Jan; 60(1):68-75. PubMed ID: 6121616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanylate cyclase activation by organic nitrates is not mediated via nitrite.
    Romanin C; Kukovetz WR
    J Mol Cell Cardiol; 1988 May; 20(5):389-96. PubMed ID: 2905390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse relaxation responses of canine large and small conductive coronary arteries to glyceryl trinitrate and nitric oxide on the one hand and to 8-bromoguanosine 3':5' cyclic monophosphate on the other.
    Kitagawa T; Ishibashi T; Imai S
    Jpn J Pharmacol; 1998 Jan; 76(1):101-4. PubMed ID: 9517410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desensitization to nitroglycerin in vascular smooth muscle from rat and human.
    Waldman SA; Rapoport RM; Ginsburg R; Murad F
    Biochem Pharmacol; 1986 Oct; 35(20):3525-31. PubMed ID: 2876710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascorbate activates soluble guanylate cyclase via H2O2-metabolism by catalase.
    Cherry PD; Wolin MS
    Free Radic Biol Med; 1989; 7(5):485-90. PubMed ID: 2575561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.
    Arnold WP; Mittal CK; Katsuki S; Murad F
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3203-7. PubMed ID: 20623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase.
    Sorajja P; Cable DG; Hamner CE; Schaff HV
    J Surg Res; 2005 Jan; 123(1):82-8. PubMed ID: 15652954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.